Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Renal Pelvis Urothelial Carcinoma"
Page 1
Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure.
Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Raymond R. Cozad SC, et al. Urology. 1995 Dec;46(6):796-800. doi: 10.1016/S0090-4295(99)80346-X. Urology. 1995. PMID: 7502418
OBJECTIVES: To identify recurrence patterns and possible indications for adjuvant treatment. METHODS: Ninety-four patients with transitional cell carcinoma of the renal pelvis or ureter were reviewed to determine their pattern of failure. ...Twe …
OBJECTIVES: To identify recurrence patterns and possible indications for adjuvant treatment. METHODS: Ninety-four patients with transitio …
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, Rosenberg JE, Bajorin DF. Tully CM, et al. Cancer. 2016 Mar 1;122(5):712-21. doi: 10.1002/cncr.29801. Epub 2015 Nov 30. Cancer. 2016. PMID: 26618338 Free PMC article.
BACKGROUND: The current study compared the incidence of vascular thromboembolic events (VTEs) in patients with metastatic or unresectable urothelial carcinoma (UC) who were treated with gemcitabine and carboplatin (GCb); gemcitabine, carboplatin, and bevacizu …
BACKGROUND: The current study compared the incidence of vascular thromboembolic events (VTEs) in patients with metastatic or unresectable …
Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response.
Igawa M, Urakami S, Shiina H, Ishibe T, Kadena H, Usui T. Igawa M, et al. Br J Urol. 1995 Sep;76(3):321-4. doi: 10.1111/j.1464-410x.1995.tb07708.x. Br J Urol. 1995. PMID: 7551840
PATIENTS AND METHODS: Fifty-one patients (37 men and 14 women, median age 66 years, range 41-82) with inoperable or metastatic carcinoma of the bladder, ureter or renal pelvis were treated with M-VAC and their responses evaluated for up to 7 years. ...Therefo …
PATIENTS AND METHODS: Fifty-one patients (37 men and 14 women, median age 66 years, range 41-82) with inoperable or metastatic carcinoma …